AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Transgene

Capital/Financing Update Jul 12, 2023

1715_rns_2023-07-12_463decce-92d4-4f70-ae21-684111c74f1a.pdf

Capital/Financing Update

Open in Viewer

Opens in native device viewer

PRESS RELEASE

Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2023

Strasbourg, July 12, 2023 – 06:00 pm CET

Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of June 30, 2023, the following resources were managed through the liquidity account:

    1. 279,400 shares
    1. € 154,930.00

In the first half of 2023, it was negotiated a total of:

Purchases 261,680 shares € 505,722 911
market transactions
Sales 268,716 shares € 537,401 921
market transactions

It is recalled that:

    1. as of December 31, 2022, the following resources were managed through the liquidity account:
    2. 286,436 shares
    3. € 123,251.00
    1. at the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:
    2. 164,183 shares
    3. € 246,158.00
    1. when the liquidity program was initially established in 2016, the following resources were made available:
    2. € 500,000.00

Contacts

Transgene: Lucie Larguier Director Corporate Communications & IR +33 (0)3 88 27 91 04 [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.